Table 2.
Demographic and clinical information in children positive for novel coronavirus disease 2019 (COVID-19) per age group
| Variables | ≤1 year (n=82) |
2–5 years (n=53) |
6–12 years (n=76) |
≥13 years (n=102) |
|---|---|---|---|---|
| Age, years, median (IQR) | 0 (1) | 4 (2) | 9 (4) | 15 (3) |
| Gender | ||||
| Girls | 33 (40%) | 23 (43%) | 42 (55%) | 59 (58%) |
| Boys | 49 (60%) | 30 (57%) | 34 (45%) | 43 (42%) |
| Available images | 13 (16%) | 7 (13%) | 15 (20%) | 20 (20%) |
| PICU | 4 (5%) | 2 (4%) | 5 (7%) | 8 (8%) |
| Ventilation assistance | 2 (2%) | 1 (2%) | 5 (7%) | 6 (6%) |
| Asymptomatic | 17 (21%) | 16 (30%) | 19 (25%) | 40 (39%) |
| Signs and symptoms | ||||
| Cough | 37 (45%) | 18 (34%) | 28 (37%) | 35 (34%) |
| Fever | 42 (51%) | 26 (49%) | 36 (47%) | 28 (27%) |
| Rhinorrhea | 29 (35%) | 8 (15%) | 8 (11%) | 9 (9%) |
| Headache | 0 | 2 (4%) | 15 (20%) | 18 (18%) |
| Dyspnea/shortness of breath | 13 (16%) | 3 (6%) | 6 (8%) | 13 (13%) |
| Sore throat | 2 (2%) | 2 (4%) | 10 (13%) | 12 (12%) |
| Myalgia | 0 | 1 (2%) | 2 (3%) | 11 (11%) |
| Decreased oral intake/loss of appetite | 8 (10%) | 5 (9%) | 3 (4%) | 5 (5%) |
| Vomiting | 12 (15%) | 4 (8%) | 5 (7%) | 3 (3%) |
| Chest pain/chest tightness | 0 | 0 | 7 (9%) | 8 (8%) |
| Loss of smell | 0 | 0 | 2 (3%) | 5 (5%) |
| Diarrhea/loose stools | 10 (12%) | 5 (9%) | 6 (8%) | 3 (3%) |
| Abdominal pain | 3 (4%) | 4 (8%) | 11 (14%) | 6 (6%) |
| Loss of taste | 0 | 0 | 1 (1%) | 5 (5%) |
| Irritability | 3 (4%) | 1 (2%) | 2 (3%) | 0 |
| Nausea | 0 | 0 | 3 (4%) | 2 (2%) |
| Wheezing/stridor | 1 (1%) | 2 (4%) | 1 (1%) | 0 |
| Lymphadenopathy | 1 (1%) | 0 | 1 (1%) | 0 |
IQR interquartile range, PICU pediatric intensive care unit